Host: Demondes Haynes, MD

Guest: Njira Lugogo, MD

Guest: Neil Skolnik, MD

Expert opinions from NAEPP and GINA recommend treating both symptoms and inflammation in asthma patients concomitantly. Joining Dr. Demondes Haynes to talk about these updates and therapies for asthma like short-acting beta agonists and inhaled corticosteroids are Drs. Njira Lugogo and Neil Skolnik.

This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.

Host: Demondes Haynes, MD

Guest: Njira Lugogo, MD

Guest: Neil Skolnik, MD

According to data from the CDC, over half of patients in the United States are not considered well controlled, and there hasn’t been much improvement in exacerbations as measured by ER visits or by deaths per year in the last 30 years or so. But fortunately, the use of single maintenance and reliever therapy (SMART) has been shown to help address inflammation and decrease exacerbations. Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik discuss this approach and other combination treatment for asthma.

This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.

Guest: Stephen Doyle, DO, MBA, FCCP

Guest: Navitha Ramesh, MD, FCCP

Host: Sandhya Khurana, MD, FCCP

The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes

Guest: Sandhya Khurana, MD, FCCP

Guest: Navitha Ramesh, MD

Guest: Stephen Doyle, DO, MBA, FCCP

The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal
available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes.

Host: Ryan Maves, MD

Guest: Kelly Pennington, MD

It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.

This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Host: Ryan Maves, MD

Guest: Megan Conroy, MD, MA(Ed)

Respiratory syncytial virus (RSV) is most commonly recognized for the significant disease it causes in infants and young children. However, over time its prevalence in adults has increased. Tune in to learn more with Dr. Ryan Maves as he speaks with Dr. Megan Conroy, Assistant Professor of Medicine at the Ohio State University in Columbus.

This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.

Host: Ryan Maves, MD

Guest: Kelly Pennington, MD

It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.

Host: Ashwin Basavaraj, MD

Guest: Christopher Lippincott, MD, MPH

Bronchiectasis is a complex syndrome that can lead to an interconnected cascade of airway dysfunction and inflammation. How has our understanding of this syndrome evolved with Cole’s vicious cycle hypothesis? Dr. Ashwin Basavaraj and Dr. Christopher Lippincott take a closer look at this hypothesis and the clinical mechanisms behind bronchiectasis.

This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Guest: Ashwin Basavaraj, MD

Host: Christopher Lippincott, MD, MPH

From airway clearance techniques and mucoactive therapy—what can clinicians do to manage bronchiectasis exacerbations? To answer this question, Dr. Christopher Lippincott and Dr. Ashwin Basavaraj explore the mechanisms that lead to bronchiectasis and share strategies to manage exacerbations.

This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.

Host: Navitha Ramesh, MD, FCCP

Guest: Allen Blaivas, DO, FCCP

When selecting the right delivery device for your patient with COPD, there are a lot of factors to consider. To help us better understand these key components, Dr. Navitha Ramesh and Dr. Allen Blaivas from the Rutgers New Jersey Medical School discuss nebulizer therapy, delivery devices, and patient education.

This is a non-promotional, non-CME disease state educational program brought to you by CHEST. Sponsored by Theravance BioPharma and Viatris.